How long should I wait after receiving an MMR (Measles, Mumps, and Rubella) booster vaccine before becoming pregnant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MMR Vaccine and Pregnancy Planning: Recommended Waiting Period

Women should avoid pregnancy for 3 months (28 days minimum) after receiving the MMR vaccine before attempting to become pregnant. 1

Rationale and Guidelines

  • The Advisory Committee on Immunization Practices (ACIP) recommends that women avoid pregnancy for 3 months after receiving MMR or other rubella-containing vaccines due to theoretical concerns about potential risk to the fetus 2, 1
  • For monovalent measles or mumps vaccines, women should avoid pregnancy for at least 30 days after vaccination 2, 1
  • The most recent guidance specifies a minimum waiting period of 28 days after receipt of rubella-containing vaccine before attempting pregnancy 1
  • This recommendation is based on theoretical concerns, as the MMR vaccine contains live attenuated viruses that could potentially affect fetal development 2

Scientific Evidence and Safety Data

  • The recommendation for pregnancy avoidance is precautionary - the risk is theoretical rather than based on documented cases of harm 1, 3
  • No cases of congenital rubella syndrome or abnormalities attributable to vaccine virus infection have been observed in infants born to susceptible women who inadvertently received MMR during pregnancy 2, 1
  • Long-term follow-up of 321 rubella-susceptible women vaccinated within 3 months before or after conception showed none of the 324 infants had malformations compatible with congenital rubella syndrome 1
  • The estimated risk for serious malformations attributable to rubella vaccine ranges from zero to 1.6% 1

Clinical Recommendations for Women Planning Pregnancy

  • Healthcare providers should ask women if they are pregnant before administering MMR and not vaccinate those who state they are pregnant 2, 1
  • Women should be counseled about the theoretical risk and advised to avoid pregnancy for 3 months after vaccination 1
  • If a woman becomes pregnant within 3 months after MMR vaccination, she should be counseled about the theoretical basis of concern, but this is not ordinarily a reason to consider pregnancy termination 2, 1

Special Considerations

  • For women who are found to be non-immune to rubella during pregnancy, vaccination should be administered immediately postpartum before discharge from the hospital or birthing center 4
  • Postpartum MMR vaccination is safe for breastfeeding women and does not pose a risk to breastfeeding infants 4
  • Women who receive MMR vaccine do not transmit the vaccine viruses to contacts, making it safe to administer to household members of pregnant women 2

Common Pitfalls to Avoid

  • Failing to screen for pregnancy before administering MMR vaccine 1
  • Unnecessarily delaying vaccination in non-pregnant women who could benefit from immunity 4
  • Recommending pregnancy termination if MMR vaccine was inadvertently administered during early pregnancy (not supported by evidence) 1
  • Confusing the waiting period recommendations between different vaccines (3 months for rubella-containing vaccines vs. 30 days for monovalent measles or mumps vaccines) 2, 1

By following these evidence-based recommendations, women can safely receive the MMR vaccine when indicated and plan pregnancy appropriately to minimize any theoretical risks while ensuring protection against these potentially serious infections.

References

Guideline

MMR Vaccine and Pregnancy Avoidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Measles, mumps, and rubella.

Clinical obstetrics and gynecology, 2012

Guideline

Rubella Vaccination for Non-Immune Postpartum Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.